Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
IYK vs. KXI: A Closer Look at U.S. vs. Global Consumer Staples ETFs

IYK vs. KXI: A Closer Look at U.S. vs. Global Consumer Staples ETFs

Key Takeaways

  • IYK is a U.S.-only, concentrated consumer staples fund with roughly 54 holdings, while KXI offers broader global exposure across roughly 95–110 developed-market companies.
  • Both funds charge a 0.38% expense ratio, but their diversification profiles differ sharply: IYK's top ten positions represent about 66% of assets versus roughly 50% for KXI.
  • IYK carries a structural quirk — a meaningful allocation to healthcare distribution names such as CVS and MCK — while KXI stays closer to a pure consumer staples mandate with retail leaders WMT and COST.
  • KXI provides geographic diversification (U.S., United Kingdom, Japan, and other developed markets) and adds currency exposure, whereas IYK isolates U.S. dollar risk only.
  • Tickeron AI Verdict: KXI — its broader diversification, lower single-stock concentration, and global reach give it a more balanced risk profile in the current environment.

Introduction

Consumer staples ETFs are drawing renewed attention as investors weigh defensive positioning against shifting inflation, rate, and currency dynamics. IYK and KXI are natural candidates for an ETF comparison, because both target companies that sell essential goods yet take different paths to that goal. IYK focuses on the U.S. consumer staples sector with a concentrated portfolio, while KXI spans the global consumer staples universe. They do not compete head-to-head so much as represent two expressions of the same defensive theme, making their relative positioning a useful lens for investors evaluating sector exposure and fund performance. I checked the sector overlap using Tickeron’s AI tools to confirm the key differences in scope.

A Closer Look at IYK

IYK is a passively managed fund that seeks to track the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, a benchmark of U.S. equities in the consumer staples sector. The fund holds roughly 54 securities, making it notably concentrated for a sector ETF. Its top holdings include PG, KO, PM, PEP, CVS, MO, MCK, MDLZ, and CL.

Sector allocation is weighted toward food, beverage, and tobacco (roughly 55%), followed by household and personal products (about 21%), with a distinctive healthcare equipment and services sleeve near 13% — a structural feature reflecting holdings like CVS and McKesson that most pure staples funds exclude. Consumer staples distribution and retail accounts for about 7%, with a small materials allocation. The expense ratio is 0.38%. Launched in 2000, IYK offers a liquid, U.S.-focused vehicle with a defensive, income-oriented tilt.

A Closer Look at KXI

KXI is a passively managed fund that tracks the S&P Global 1200 Consumer Staples Sector Capped Index, providing market-cap-weighted exposure to consumer staples companies across developed markets. The fund holds roughly 95 to 110 securities, offering meaningfully broader diversification than IYK. Top holdings include WMT, COST, PG, KO, PM, and PEP, alongside international names such as Nestlé, Unilever, and British American Tobacco. I also ran a quick scan with Tickeron’s AI Screener to cross-check the international names against U.S. peers.

Geographically, KXI remains heavily weighted to the United States (roughly 60%), with meaningful United Kingdom and Japan exposure and additional developed-market holdings. The fund is essentially a pure consumer staples play, with food, beverage, tobacco, household products, and retail distribution dominating the portfolio. The expense ratio is 0.38%. Introduced in 2006, KXI provides global diversification and currency exposure within a single defensive sector sleeve.

The Broader Context for Staples Investing

Both ETFs operate within the consumer staples complex, a defensive area known for relatively stable demand across economic cycles. Recent months have featured a tug-of-war between inflation persistence, central bank rate expectations, and currency movements — all of which influence these funds differently. A stronger U.S. dollar tends to pressure KXI's international earnings when translated back into dollars, while IYK remains insulated from that effect. Conversely, KXI's global reach can benefit from regional pricing power and diversification away from any single economy's consumer slowdown.

Other catalysts include shifting commodity costs for raw materials and packaging, the growth of GLP-1 weight-loss drugs and their potential impact on food and beverage demand, and regulatory scrutiny on tobacco and household product ingredients. Capital flows into defensive sectors have fluctuated as investors weigh valuation against quality, favoring lower-volatility, dividend-paying businesses during periods of uncertainty.

How the Two Funds Compare in Practice

Across recent market cycles, both funds have exhibited the low-beta, lower-volatility behavior typical of consumer staples, though their drivers differ. IYK's concentrated U.S. exposure and healthcare distribution sleeve have historically contributed to solid relative performance, helped by the pricing power of mega-cap staples and resilient pharmaceutical distribution demand. KXI's performance has been shaped more by global retail leaders Walmart and Costco, which have shown relative strength on consumer trade-down and membership growth, alongside international staples franchises.

KXI's broader holdings base and geographic spread generally translate into lower single-stock concentration risk but introduce currency sensitivity. IYK's narrower portfolio amplifies the influence of its top names and its unusual healthcare weighting. In terms of relative positioning, KXI has benefited from a blend of defensive U.S. retail leadership and global diversification, while IYK offers a more concentrated bet on U.S. staples and healthcare distribution. Volatility differences remain modest, but the structural profiles suggest KXI is the more balanced of the two.

Tickeron AI Verdict

Based on observable structural factors, Tickeron's AI would likely favor KXI over IYK in the current environment. KXI combines a comparable 0.38% cost with a materially broader portfolio, lower top-ten concentration, and geographic diversification that reduces dependence on any single economy or currency regime. Its exposure to resilient global retail leaders and established international staples franchises supports more balanced relative positioning. While IYK's concentrated U.S. quality and healthcare tilt can outperform in specific conditions, KXI's superior diversification and smoother risk profile make it the more probabilistically favored choice for a defensive core holding.

Enhancing My ETF Research Workflow

When comparing funds like these, I frequently rely on Tickeron's AI Screener to scan for similar ETFs and evaluate their technical and fundamental profiles side by side. It streamlines the process of identifying diversification opportunities and has become a regular part of my analysis routine, helping surface nuances that manual reviews sometimes miss.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IYK, KXI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IYK's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 70 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.

Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Bearish Trend Analysis

The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 30 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 61 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

IYK broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Philip Morris International (NYSE:PM), PepsiCo (NASDAQ:PEP), Altria Group (NYSE:MO), McKesson Corp (NYSE:MCK), CVS HEALTH Corp (NYSE:CVS), Mondelez International (NASDAQ:MDLZ), Colgate-Palmolive Company (NYSE:CL), Kroger Co (The) (NYSE:KR).

Industry description

The investment seeks to track the investment results of the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index composed of U.S. equities in the consumer staples sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index, The underlying index measures the performance of the consumer staples sector of the U.S. equity market. It is non-diversified.

Market Cap

The average market capitalization across the iShares U.S. Consumer Staples ETF (IYK) ETF is 49.58B. The market cap for tickers in the group ranges from 3.35B to 412.31B. KO holds the highest valuation in this group at 412.31B. The lowest valued company is FRPT at 3.35B.

High and low price notable news

The average weekly price growth across all stocks in the iShares U.S. Consumer Staples ETF (IYK) ETF was 2%. For the same ETF, the average monthly price growth was 11%, and the average quarterly price growth was 11%. TAP experienced the highest price growth at 8%, while SFM experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the iShares U.S. Consumer Staples ETF (IYK) ETF was 59%. For the same stocks of the ETF, the average monthly volume growth was 6% and the average quarterly volume growth was -2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 49
Price Growth Rating: 44
SMR Rating: 58
Profit Risk Rating: 71
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
IYK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category ConsumerStaples

Category
Consumer Defensive
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $17.78 billion, up 39.7% year-over-year from $12.73 billion in Q1 2025. Consensus non-GAAP EPS forecast at $7.26, reflecting robust demand for key products.
Analysts expect Q1 2026 EPS of $4.41, up 18% year-over-year from $3.73. Consensus revenue forecast stands at $8.26 billion, reflecting 14% growth.